Avid Bioservices logo
Avid Bioservices CDMO

Quarterly report 2024-Q3
added 12-10-2024

report update icon

Avid Bioservices Total Current Liabilities 2011-2026 | CDMO

Annual Total Current Liabilities Avid Bioservices

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
70.6 M 215 M 223 M 70.9 M 44.5 M 23.2 M 37.9 M 62.9 M 57.6 M 37.3 M 22.2 M 20.6 M 17.6 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
223 M 17.6 M 69.5 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
AIkido Pharma AIkido Pharma
AIKI
1.61 M - 1.93 % $ 17.4 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
15.7 M - 3.16 % $ 1.9 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
6.18 M - 10.36 % $ 9.8 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
1.1 M - -52.27 % $ 4.45 M usaUSA
AVROBIO AVROBIO
AVRO
6.35 M - 1083.1 % $ 745 M usaUSA
Axcella Health Axcella Health
AXLA
14.1 M - -16.42 % $ 249 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
1.83 B - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
200 M - - $ 546 M usaUSA
Allakos Allakos
ALLK
36.6 M - - $ 28.6 M usaUSA
Brickell Biotech Brickell Biotech
BBI
1.66 M - -5.38 % $ 6.06 M usaUSA
Atreca Atreca
BCEL
16.3 M - -11.76 % $ 5.79 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
13.2 M - - $ 35.4 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
ChemoCentryx ChemoCentryx
CCXI
63 M - - $ 3.74 B usaUSA
AlloVir AlloVir
ALVR
9.71 M - 4.14 % $ 49.1 M usaUSA
Завод ДИОД Завод ДИОД
DIOD
105 M - - - russiaRussia
Фармсинтез Фармсинтез
LIFE
1.02 B - - - russiaRussia
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
5.4 M - -74.18 % $ 955 K usaUSA
Chimerix Chimerix
CMRX
18.4 M - - $ 756 M usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
23.1 M - -13.85 % $ 16.1 M usaUSA
AbbVie AbbVie
ABBV
43.3 B $ 208.7 -0.07 % $ 369 B usaUSA
Calithera Biosciences Calithera Biosciences
CALA
14 M - -10.95 % $ 876 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
11 M - -3.03 % $ 260 M usaUSA
Viela Bio, Inc. Viela Bio, Inc.
VIE
46 M - - $ 2.91 B usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
64.3 M $ 3.52 -0.14 % $ 1.05 B canadaCanada